Pune, Aug. 06, 2019 (GLOBE NEWSWIRE) -- The global vitiligo treatment market is likely to gain impetus from an ever rising demand for innovative and modern treatment options for vitiligo. According to Fortune Business Insights, titled, “Vitiligo Treatment Market: Global Market Analysis, Insights and Forecast, 2019-2026,” the global vitiligo treatment market was valued at US$ 1,243.8 Mn in 2018. The market is projected to reach US$ 1,944.5 Mn by 2026, exhibiting a CAGR of 5.8% in the forecast period.
In terms of treatment, the global vitiligo treatment market is grouped into topical treatment, surgical procedures, light therapy, and others. Amongst these, the topical treatment segment had held majority of the vitiligo treatment market share. This is because of the increasing patient pool, need for numerous treatment methods for vitiligo, and an increasing number of research and development activities. However, lack of awareness regarding the available vitiligo treatment and reduction in the diagnosis rate may hamper the vitiligo treatment market growth.
Browse Complete Report Details with Table of Content and Figures:
https://www.fortunebusinessinsights.com/industry-reports/vitiligo-treatment-market-100580
Increasing Number of Vitiligo Patients to Favor Growth in Asia Pacific
The global vitiligo treatment market is geographically divided into North America, Latin America, the Middle East and Africa, Europe, and Asia Pacific. Amongst these, in Asia Pacific, India, China, and the other Southeast Asian countries have been witnessing huge patient pools of vitiligo. This has further resulted in an urgent requirement for effective treatment options available of vitiligo. The markets of Latin America and the Middle East and Africa, on the other hand are expected witness notable grow in the near future. This is because darker skinned individuals who suffer from vitiligo are demanding for modern methods of treatment that would help the condition become less noticeable on them.
In North America, the vitiligo treatment market was valued at US$ 314.1 Mn in 2018. This is because of a rise in the research and development activities and an increasing adoption of vitiligo treatment. Numerous healthcare providers in the U.S., are also implementing advanced technologies in the treatment of vitiligo. Also, the number of vitiligo affected populace is growing rapidly there. In Europe, an unmet need for advanced treatment options is likely to boost vitiligo treatment market growth. Fortune Business Insights predicts that Asia Pacific will witness a remarkably high CAGR during the forthcoming years. This is likely to occur because of huge patient pool in the region.
Key Players Focus on Effective Medicine Launch to Strengthen Market Position
Incyte Corporation, a pharmaceutical company, based in the U.S., announced the result of its dose-ranging, randomized, vehicle-controlled, and double-blind Phase 2 study evaluating ruxolitinib cream, an anti-inflammatory, nonsteroidal, and JAK inhibitor therapy in patients with vitiligo between the age group of 18 to 75 years of age. The results were out after 24 weeks. The study met its primary goal and treated many patients with the help of ruxolitinib cream for 24 weeks. The results were presented at the 24th World Congress of Dermatology in Italy. The positive result supports the potential of ruxolitinib cream in providing novel treatment for chronic autoimmune disease.
Sample PDF https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/vitiligo-treatment-market-100580
Dr. Reddy’s Laboratories Ltd., a multinational pharmaceutical company, headquartered in Hyderabad, announced the launch of Melgain in June 2014. Melgain is a lotion that is considered to be the first peptide-based drug for vitiligo. The lotion is effective and very safe to use for the treatment of vitiligo for children and adults.
Fortune Business Insights profiles some of the most prominent companies operating in the global vitiligo treatment market. Some of them are Bausch Health Companies Inc., Dr. Reddy’s Laboratories Ltd., Incyte Corporation, Puneet Laboratories Pvt. Ltd, Astellas Pharma Inc., Baxter International Inc., and other players.
Vitiligo Treatment Market Players
- Incyte Corporation
- Astellas Pharma Inc.
- Bausch Health Companies Inc.
- Baxter International Inc.
- Pfizer Inc.
- STRATA Skin Sciences
- Reddy’s Laboratories Ltd.
- Other players
Speak to Analyst https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/vitiligo-treatment-market-100580
Table of Content:
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of vitiligo by key countries
- Pipeline analysis
- Recent industry developments - mergers & acquisitions
- Recent developments in R&D
- Global Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Treatment
- Topical Treatment
- Light Therapy
- Surgical Procedures
- Others
- Market Analysis, Insights and Forecast – By Disease Type
- Nonsegmental Vitiligo
- Segmental Vitiligo
- Market Analysis, Insights and Forecast – By End-user
- Hospitals
- Aesthetic Clinics
- Others
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia pacific
- Latin America
- Middle East & Africa
- Competitive Analysis
- Strategic Recommendations
Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/vitiligo-treatment-market-100580
Browse Related Reports:
- Advanced Wound Care Market Size, Share and Global Trend by Product (Advanced Wound Dressings, Wound Care Devices & Active Wound Care), Indication (Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds, Others), End User and Geography Forecast till 2025
- Cardiovascular Stents Market Size, Share and Global Trend by Product Type (Coronary Stenting, Peripheral Stenting), Stent Type (Drug Eluting Stents (DES), Bioresorbable Stents, Bare Metal Stents & Others), Disease Indication (Venous Disease, Arterial Disease), End User and Geography Forecast by 2025
- Molecular Diagnostics Market Size, Share and Global Trend by Product Type (Instruments Reagents & Consumables), Application (Infectious Disease, Blood Screening, Histology & Oncology), Technique (Hospitals Amplification, Hybridization & Sequencing Techniques), End User (Hospitals, Clinical & Pathology Labs) and Geography Forecast till 2025
- Thrombin Market Size, Share and Global Trend by Product (Bovine Thrombin, Human Thrombin, Recombinant Thrombin), By Dosage Form (Powder Form, Solution Form), By End user (Hospitals, Diagnostics Centers & Clinics, Academics and Research Institutes), and Geography Forecast till 2026
About us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
US :+1-424-253-0390
UK :+44-2071-939123
APAC :+91-744-740-1245
Email: sales@fortunebusinessinsights.com
Website: https://www.fortunebusinessinsights.com